Defining Target Volumes for Stereotactic Ablative Radiotherapy of Early-stage Lung Tumours: A Comparison of Three-dimensional 18F-fluorodeoxyglucose Positron Emission Tomography and Four-dimensional Computed Tomography

Clinical Oncology

Volumn 24, Issue 6, 2012, Pages

  Hanna, G G ^a,b   Van Sornsen de Koste J R ^a   Dahele, M R ^a   Carson, K J ^c   Haasbeek, C J A ^a   Migchielsen, R ^a   Hounsell, A R ^b   Senan, S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Four dimensional CT; NSCLC; PET CT; Stereotactic ablative radiotherapy; Target volume definition

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HUMAN; INTERMETHOD COMPARISON; INTERNAL TARGET VOLUME; LUNG NON SMALL CELL CANCER; MANUAL CONTOURING; MAXIMUM INTENSITY PROJECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; STANDARDISED UPTAKE VALUE; STEREOTACTIC BODY RADIATION THERAPY; THREE DIMENSIONAL IMAGING; TUMOR ABLATION; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOSURGERY;

EID: 84863845167     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.03.002     Document Type: Article

References (38)

1. Senan S., Lagerwaard F. Stereotactic radiotherapy for stage I lung cancer: current results and new developments. Cancer Radiother 2010, 14(2):115-118.
2. Grutters J.P., Kessels A.G., Pijls-Johannesma M., De Ruysscher D., Joore M.A., Lambin P. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol 2010, 95(1):32-40.
3. Lagerwaard F.J., Haasbeek C.J.A., Smit E.F., et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70:685-692.
4. Grills I.S., Mangona V.S., Welsh R., et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010, 28(6):928-935.
5. Baumann P., Nyman J., Hoyer M., et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009, 27:3290-3296.
6. Chang J.Y., Balter P.A., Dong L., et al. Stereotactic body radiotherapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 72:967-971.
7. Sangha V., Prestwich R., Lilley J., et al. Feasibility and early outcomes of stereotactic radiotherapy in early lung cancer at St. James's Institute of Oncology. Clin Oncol (R Coll Radiol) 2011, 23:S51-S52.
8. Brown W.T., Wu X., Fayad F., et al. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent. Clin Oncol (R Coll Radiol) 2009, 21:623-631.
9. Martin A., Gaya A. Stereotactic body radiotherapy: a review. Clin Oncol (R Coll Radiol) 2010, 22:157-172.
10. Senan S., De Ruysscher D., Giraud P., Mirimanoff R., Budach V. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 2004, 71(2):139-146. Radiotherapy Group of European Organization for Research and Treatment of Cancer.
11. Keall P.J., Mageras G.S., Balter J.M., et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 2006, 33(10):3874-3900.
12. Underberg R.W.M., Lagerwaard F.J., Slotman B.J., et al. Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer. Int J Radiat Oncol Biol Phys 2005, 63:253-260.
13. Bradley J.D., Nofal A.N., El Naqa I.M., et al. Comparison of helical, maximum intensity projection (MIP), and averaged intensity (AI) 4D CT imaging for stereotactic body radiation therapy (SBRT) planning in lung cancer. Radiother Oncol 2006, 81:264-268.
14. Rietzel E., Liu A.K., Chen G.T.Y., Choi N.C. Maximum-intensity volumes for fast contouring of lung tumors including respiratory motion in 4DCT planning. Int J Radiat Oncol Biol Phys 2008, 71:1245-1252.
15. Toloza E., Harpole L., Detterbeck F., McCrory D. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003, 123:137S-146S.
16. 18FDG-positron emission tomography in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007, 67:709-719.
17. Ung Y.C., Bezjak A., Coakley N., Evans W.K. Positron emission tomography with 18fluorodeoxyglucose in radiation treatment planning for non-small cell lung cancer: a systematic review. J Thorac Oncol 2011, 6:86-97.
18. Hanna G.G., McAleese J., Carson K.J., et al. 18F-FDG PET-CT simulation for non-small cell lung cancer: what is the impact in patients already staged by PET-CT?. Int J Radiat Oncol Biol Phys 2010, 77:24-30.
19. Caldwell C.B., Mah K., Skinner M., Danjoux C.E. Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET. Int J Radiat Oncol Biol Phys 2003, 55:1381-1393.
20. Okubo M., Nishimura Y., Nakamatsu K., et al. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system. Ann Nucl Med 2008, 22:579-586.
21. Bral S., Van Parijs H., Soete G., et al. A feasibility study of image-guided hypofractionated conformal arc therapy for inoperable patients with localized non-small cell lung cancer. Radiother Oncol 2007, 84:252-256.
22. Schaefer A., Kremp S., Hellwig D., et al. A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data. Eur J Nucl Med Mol Imaging 2008, 35:1989-1999.
23. Boellaard R., Krak N.C., Hoekstra O.S., Lammertsma A.A. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 2004, 45:1519-1527.
24. MacManus M.P., Hicks R.J. Where do we draw the line? Contouring positron emission tomography/computed tomography. Int J Radiat Oncol Biol Phys 2008, 71:2-4.
25. Boellaard R., Oyen W.J.G., Hoekstra C.J., et al. The Netherlands Protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 2008, 35:2320-2333.
26. Hanna G.G., McManus K.G., Lynch T., et al. What is the shelf life of PET-CT staging of the mediastinum in non-small cell lung cancer?. Lung Cancer 2009, 63:S24.
27. 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 2005, 46:1342-1348.
28. Davis J.B., Reiner B., Huser M., Burger C., Székely G., Ciernik I.F. Assessment of 18F PET signals for automatic target volume definition in radiotherapy treatment planning. Radiother Oncol 2006, 80:43-50.
29. Schreibmann E., Thorndyke B., Li T., Wang J., Xing L. Four-dimensional image registration for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2008, 71:578-586.
30. Dice L.R. Measures of the amount of ecologic association between species. Ecology 1945, 26:297-302.
31. Hanna G.G., Hounsell A.R., O'Sullivan J.M. Geometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods. Clin Oncol (R Coll Radiol) 2010, 22:515-525.
32. MacManus M.P., Wong K., Hicks R.J., et al. Early mortality after radical radiotherapy for non-small cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral centre. Int J Radiat Oncol Biol Phys 2002, 52:351-361.
33. Bradley J., Thorstad W.L., Mutic S., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004, 59:78-86.
34. El Naqa I., Low D.A., Bradley J.D., et al. Deblurring of breathing motion artifacts in thoracic PET images by deconvolution methods. Med Phys 2006, 33:3587-3600.
35. Park S.J., Ionascu D., Killoran J., et al. Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images. Phys Med Biol 2008, 53:3661-3679.
36. Pan T., Mawlawi O. PET/CT in radiation oncology. Med Phys 2008, 35:4955-4966.
37. Riegel A.C., Bucci M.K., Mawlawi O.R., et al. Target definition of moving lung tumors in positron emission tomography: correlation of optimal activity concentration thresholds with object size, motion extent, and source-to-background ratio. Med Phys 2010, 37(4):1742-1752.
38. Perrin R., Evans P.M., Webb S., Partridge M. The use of PET images for radiotherapy treatment planning: an error analysis using radiobiological endpoints. Med Phys 2010, 37:516-531.